The landscape of non-cystic fibrosis bronchiectasis (NCFB) treatment is undergoing a significant transformation with the emergence of Brinsupri (brensocatib), a…
Read More
Salesforce lands 140 life sciences clients, pitches ‘headless’ AI to pharma
In a strategic maneuver that underscores the intensifying competition in the life sciences technology sector, Salesforce has announced that over…
Read More
Revolution Medicines’ Daraxonrasib Achieves Landmark Survival Extension in Pancreatic Cancer, Heralding New Era of Targeted Therapy
The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer. The 2026…
Read More
ASCO 2026: Lung Cancer Landscape Ignites with Promising Bispecifics, Targeted Therapies, and Extended Survival Data
The annual American Society of Clinical Oncology (ASCO) congress, a cornerstone event for the global oncology community, convened in Chicago,…
Read More
Eli Lilly and Company Secures Global Rights to Hanmi Pharm’s Sonefpeglutide in Potential $1.26 Billion Deal
Eli Lilly and Company has forged a significant licensing agreement with South Korean biopharmaceutical firm Hanmi Pharm, potentially worth up…
Read More
Chinese firms landed 6 of 26 major pharma deals in 16 months, worth $53 billion
Over the past 16 months, Chinese-domiciled biopharmaceutical companies have emerged as significant players in the global drug development landscape, participating…
Read More
AbbVie Secures FDA Approval for Ultra-Rare Blood Cancer Therapy, While AstraZeneca Faces Delay for Breast Cancer Drug
The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
Protecting Innovation in a Borderless Pharma Economy: The Reality of Globalized Pharma Innovation
The pharmaceutical industry, a bedrock of global health and economic advancement, is increasingly defined by its borderless nature. Today’s drug…
Read More
The Dawn of Psychedelics in Medicine: Navigating the Path to Safe and Effective Implementation
The landscape of mental healthcare is on the cusp of a significant transformation with the burgeoning approval of psychedelic-assisted therapies.…
Read More
Top Pharma Companies Set Sustainability Goals, But Emissions Are Still Increasing
The healthcare industry, a cornerstone of global well-being, paradoxically contributes an estimated 4.4% of total global emissions annually, placing it…
Read MoreYOU MAY HAVE MISSED
